Technical Analysis for AZTR - Azitra Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | -0.36% | |
Outside Day | Range Expansion | -0.36% | |
Up 3 Days in a Row | Strength | -0.36% | |
Up 4 Days in a Row | Strength | -0.36% | |
Oversold Stochastic | Weakness | -0.36% | |
Stochastic Buy Signal | Bullish | 0.62% | |
Bollinger Band Squeeze | Range Contraction | 0.62% | |
NR7 | Range Contraction | 0.62% | |
Narrow Range Bar | Range Contraction | 0.62% | |
BB Squeeze Started | Range Contraction | 0.62% |
Alert | Time |
---|---|
Gap Down Partially Closed | about 1 hour ago |
Gap Down Closed | about 1 hour ago |
60 Minute Opening Range Breakout | about 1 hour ago |
Down 3% | about 1 hour ago |
Up 1% | about 1 hour ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 68.4 |
52 Week Low | 0.4264 |
Average Volume | 239,553 |
200-Day Moving Average | 4.14 |
50-Day Moving Average | 0.53 |
20-Day Moving Average | 0.50 |
10-Day Moving Average | 0.49 |
Average True Range | 0.05 |
RSI (14) | 39.76 |
ADX | 14.43 |
+DI | 17.13 |
-DI | 21.02 |
Chandelier Exit (Long, 3 ATRs) | 0.47 |
Chandelier Exit (Short, 3 ATRs) | 0.56 |
Upper Bollinger Bands | 0.55 |
Lower Bollinger Band | 0.45 |
Percent B (%b) | 0.24 |
BandWidth | 20.44 |
MACD Line | -0.02 |
MACD Signal Line | -0.02 |
MACD Histogram | -0.0008 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.51 | ||||
Resistance 3 (R3) | 0.50 | 0.49 | 0.50 | ||
Resistance 2 (R2) | 0.49 | 0.48 | 0.49 | 0.50 | |
Resistance 1 (R1) | 0.48 | 0.48 | 0.49 | 0.48 | 0.50 |
Pivot Point | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Support 1 (S1) | 0.46 | 0.46 | 0.46 | 0.46 | 0.44 |
Support 2 (S2) | 0.44 | 0.45 | 0.44 | 0.44 | |
Support 3 (S3) | 0.43 | 0.44 | 0.44 | ||
Support 4 (S4) | 0.43 |